In 2024, Esperite's equity was 0 EUR, a 0% increase from the 0 EUR equity in the previous year.

Esperite Aktienanalyse

What does Esperite do?

Esperite NV is a company based in the Netherlands that specializes in the development, production, and marketing of stem cell and cell therapies. It focuses on creating groundbreaking therapies for the treatment of serious diseases and aims to market them worldwide. Its business model includes three main segments: Life Science, Consumer Healthcare, and Branding. The Life Science segment focuses on developing stem cell and cell therapies for the treatment of diseases such as autism, cancer, and degenerative disorders. The Consumer Healthcare segment offers products related to pregnancy and fertility assistance. The Branding segment involves the development and marketing of high-quality cosmetic products. Esperite's flagship product is CryoSave, a solution for the long-term preservation of stem cells from umbilical cord blood. Esperite ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Esperite's Equity

Esperite's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Esperite's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Esperite's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Esperite's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Esperite’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Esperite stock

What is the equity of Esperite this year?

Esperite has equity of 0 EUR this year.

What was the equity of Esperite compared to the previous year?

The equity of Esperite has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Esperite?

A high equity is advantageous for investors of Esperite as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Esperite?

A low equity can be a risk for investors of Esperite, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Esperite affect the company?

An increase in equity of Esperite can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Esperite affect the company?

A reduction in equity of Esperite can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Esperite?

Some factors that can affect the equity of Esperite include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Esperite so important for investors?

The equity of Esperite is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Esperite take to change the equity?

To change equity, Esperite can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Esperite pay?

Over the past 12 months, Esperite paid a dividend of 0.08 EUR . This corresponds to a dividend yield of about 869.57 %. For the coming 12 months, Esperite is expected to pay a dividend of 0 EUR.

What is the dividend yield of Esperite?

The current dividend yield of Esperite is 869.57 %.

When does Esperite pay dividends?

Esperite pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Esperite?

Esperite paid dividends every year for the past 0 years.

What is the dividend of Esperite?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Esperite located?

Esperite is assigned to the 'Health' sector.

Wann musste ich die Aktien von Esperite kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Esperite from 6/14/2012 amounting to 0.08 EUR, you needed to have the stock in your portfolio before the ex-date on 5/18/2012.

When did Esperite pay the last dividend?

The last dividend was paid out on 6/14/2012.

What was the dividend of Esperite in the year 2023?

In the year 2023, Esperite distributed 0 EUR as dividends.

In which currency does Esperite pay out the dividend?

The dividends of Esperite are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Esperite

Our stock analysis for Esperite Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Esperite Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.